Table: Kobayashi Pharmaceutical - 6-MTH group results
Aug 8 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2023 Jun 30, 2022 Dec 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 73.63 71.26 172.00
(+3.3 pct) (+6.3 pct) (+3.5 pct)
Operating 10.41 9.87 25.50
(+5.5 pct) (-3.6 pct) (-4.4 pct)
Recurring 11.17 10.90 26.50
(+2.5 pct) (-1.7 pct) (-6.3 pct)
Net 7.86 7.70 20.20
(+2.1 pct) (-2.3 pct) (+0.9 pct)
EPS 103.35 yen 99.55 yen 265.74 yen
Ann Div 90.00 yen 96.00 yen
-Q2 div 43.00 yen 38.00 yen
-Q4 div 52.00 yen 53.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows